Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $152.2500 (-0.57%) ($151.3700 - $153.8300) on Thu. Sep. 28, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.12% (three month average) | RSI | 64 | Latest Price | $152.2500(-0.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) DIA(53%) IBB(51%) VYM(50%) SPLV(49%) | Factors Impacting ABBV price | ABBV will decline at least -0.56% in a week (0% probabilities). VXX(-34%) VIXM(-31%) USO(-23%) TBT(-19%) BNDX(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.56% (StdDev 1.12%) | Hourly BBV | -1.1 () | Intraday Trend | -0.9% | | | |
|
5 Day Moving Average | $153.34(-0.71%) | 10 Day Moving Average | $153.33(-0.7%) | 20 Day Moving Average | $151.21(0.69%) | To recent high | -1.6% | To recent low | 14.9% | Market Cap | $268.612b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |